Indication
Atrial Fibrillation Recurrent
3 clinical trials
3 products
1 drug
Clinical trial
Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation - A Randomized Open-Label Phase III TrialStatus: Active (not recruiting), Estimated PCD: 2026-11-30
Product
DapagliflozinClinical trial
SPironolactONe for the Maintenance of Sinus Rhythm in Hypertensive Patients With Atrial Fibrillation and Preserved Left Ventricular Ejection Fraction (SPONSoR Study).Status: Not yet recruiting, Estimated PCD: 2028-01-01
Product
SpironolactoneClinical trial
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Post Ablation: The EDORA TrialStatus: Terminated, Estimated PCD: 2022-12-20
Product
DronedaroneDrug
Varlilumab